Tobacco use and readiness to quit smoking in low-income HIV-infected persons

Tobacco use and readiness to quit smoking in low-income HIV-infected persons
复制标题

DOI:
10.1080/14622200500186064
复制
发表时间:
2005-08-01
影响因子:
4.7
通讯作者:
Rapkin, BD
Rapkin, BD
中科院分区:
医学2区
文献类型:
--
作者:
Burkhalter, JE;Springer, CM;Rapkin, BD

文献摘要

被引文献

相似文献

该研究的目的是确定吸烟状况和戒烟意愿的协变量,其中包括低收入艾滋病毒感染者队列中的关键社会人口统计和健康状况变量、与健康相关的生活质量、吸毒和无保护性行为以及烟草使用变量。我们还研究了艾滋病毒诊断对戒烟的影响。样本(N=428)主要是男性(59%)和黑人(53%)或西班牙裔(30%),并且受过高中或以下教育(87%)。平均年龄为 40 岁。三分之二的参与者是当前吸烟者,19% 是曾经吸烟者,16% 是从不吸烟者。目前吸烟者平均每天吸 16 支香烟,持续 22 年; 42%的人处于准备戒烟的预想阶段,40%的人正在考虑,18%的人正在准备中。目前大多数吸烟者(81%)表示接受过戒烟医疗建议。多变量逻辑回归分析表明,与以前吸烟者相比,当前吸烟者更有可能使用非法药物,认为继续吸烟的健康风险较低,并且报告的疼痛较少。与不吸烟者(以前吸烟者和从不吸烟者)相比,当前吸烟者更有可能报告在其一生中非法药物使用较多、当前非法药物使用情况以及疼痛较少。多元线性回归表明,当前非法药物使用量较大、情绪困扰较大以及戒烟尝试次数较少与戒烟准备阶段较低相关。这些发现证实了艾滋病毒感染者中吸烟的比例很高,并表明吸毒、疼痛和情绪困扰之间存在着复杂的相互作用,这些相互作用会影响吸烟状况以及吸烟者的戒烟意愿。针对艾滋病毒感染者的烟草控制计划应激发戒烟动力并解决戒烟的显着障碍,例如合并用药、情绪困扰、疼痛、获得治疗的机会和覆盖范围,并应教育吸烟者了解戒烟对艾滋病毒特有的健康益处。
The study aim was to identify covariates of smoking status and readiness to quit that encompassed key sociodemographic and health status variables, health-related quality of life, drug use and unprotected sex, and tobacco use variables in a cohort of low-income persons living with HIV. We also examined the impact of HIV diagnosis on smoking cessation. The sample (N=428) was mostly male (59'%) and Black (53%) or Hispanic (30'%), and had a high school education or less (87'Yl). Mean age was 40 years. Two-thirds of participants were current smokers, 19% former smokers, and 16% never smokers. Current smokers smoked a mean of 16 cigarettes/day for 22 years; 42% were in the precontemplation stage of readiness to quit smoking, 40% were contemplators, and 18% were in preparation. Most current smokers (81%) reported receiving medical advice to quit smoking. Multivariate logistic regression analyses indicated that current smokers, compared with former smokers, were more likely to use illicit drugs, perceive a lower health risk for continued smoking, and report less pain. Current smokers, compared with nonsmokers (former and never smokers), were more likely to report greater illicit drug use in their lifetime, current illicit drug use, and less pain. A multiple linear regression indicated that greater current illicit drug use, greater emotional distress, and a lower number of quit attempts were associated with lower stage of readiness to quit smoking. These findings confirm a high prevalence of smoking among HIV-infected persons and suggest a complex interplay among drug use, pain, and emotional distress that impact smoking status and, among smokers, readiness to quit. Tobacco control programs for HIV-infected persons should build motivation to quit smoking and address salient barriers to cessation-such as comorbid drug use, emotional distress, pain, and access to and coverage for treatment-and should educate smokers regarding the HIV-specific health benefits of cessation.